10 Aug

Massive Science | Biotechnology + Agriculture = Good for the Planet

From disease-resistant crops, to agriculture microbials that allow plants to absorb more nutrients from the earth, researchers are identifying various ways biotechnology can help feed a growing and warmer world without wrecking the environment.

In a piece for Massive Science, Marco Giovannetti with the Gregor Mendel Institute explores why GM crops are better for the environment than you think. Too often, GMOs are recklessly grouped in with agriculture practices that hurt the environment, however, as Giovannetti explains:

According to the data: not really. GM crops appear to be just as sustainable and productive as non-GM crops, if not more so.

Giovannetti goes on to note that in both aspects of “sustainability” – productivity and biodiversity – GM agriculture has outperformed non-GM crops.

“… cultivating GM crops has proven better for biodiversity than the conventional alternative, because one way to maintain biodiversity in a local ecosystem is to reduce pesticide use. A GM crop can do this by carrying its own defenses, making pesticides less necessary. For instance, “Bt” corn is engineered to be toxic to predators that would otherwise prey on it. They don’t need as much outside assistance in the form of pesticides sprayed over an entire field.”

And while some claim that pesticide-resistant crops lead to increased use of pesticides, farming data dispels that myth.

“…according to a 2014 meta-analysis, GM-based farming has required 37 percent fewer pesticides than conventional agriculture.”

Additionally, GM technology is allowing scientists to engineer plants that grow more efficiently in an increasingly populated and warmer world – requiring less resources like water and land.

As climate change progresses, land becomes more arid, usable topsoil is depleted, and water becomes more scarce. Conventional crops are typically not drought tolerant, and so as human-caused climate change continues, agricultural yields could drop. One study found that each degree of warming will result in anywhere from a 3-7 percent drop in global yield in wheat, rice, corn, and soybean. Tactics to adapt to this include engineering crops to retain more water, or adding genes that essentially stabilize cells, make them hardier, and hopefully able to withstand the stresses of a drought.

Often, those who advocate for saving the planet, are the same group that label GMOs has harmful and determinantal to the environment. However, inferring from Giovannetti’s piece, to be pro-GMO is to be pro-saving the planet.

10 Aug

Digital transformation in Health and Care

[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: H2020-SC1-DTH-2018-2020Pillar: Societal ChallengesPlanned Opening Date: Deadline: Wed, 24 Apr 2019 17:00:00 (Brussels local time)Modification Date: Fri, 10 Aug 2018Latest information: Published: 27.10.2017
Deadline: 25.04.2018
Available budget: 100 M €

Topic code

Topic short name

Overall threshold applied

SC1-DTH-03-2018

Adaptive smart working and living environments supporting active and healthy ageing

10

SC1-DTH-07-2018

Exploiting the full potential of in-silico medicine research for personalised diagnostics and therapies in cloud-based environments

10

SC1-DTH-08-2018

Prototyping aEuropean interoperable Electronic Health Record (HER) exchange

10

SC1-HCC-01-2018

Supporting investment in smart living environments for ageing well through certification

10

SC1-HCC-03-2018

Support to further development of international cooperation in digital transformation of health and care

10

SC1-HCC-04-2018

Digital Health and care services-support for strategy and (early) adoption.

10

SC1-HCC-05-2018

Support to a Digital health and Care Innovation initiative in the context of Digital Market Strategy

10

The results of the evaluation are as follows:
SC1-DTH-03-2018
Number of proposals submitted (including proposals transferred from or to other calls): 85
Number of inadmissible proposals: 0
Number of ineligible proposals: 0
Number of above-threshold proposals: 28
Total budget requested for above-threshold proposals: 110,164,991.

09 Aug

Millendo Therapeutics Goes Public With OvaScience Reverse Merger

Credit: Depositphotos image_5645691_chepko

[Corrected 2:30 p.m. See below.] Millendo Therapeutics, an Ann Arbor, MI-based biotech company developing drugs to treat endocrine diseases, is now a public company and has $30 million of new cash to continue work on its treatments for rare disorders.

Millendo announced this morning that it plans to merge with OvaScience (Nasdaq: OVAS), which was developing treatments focused on infertility and founded in 2013. The combined business will focus on Millendo’s treatments, however, and Millendo’s current shareholders will own 80 percent of the new business, which will be called Millendo Therapeutics and trade under the ticker MLND on… Read more »

UNDERWRITERS AND PARTNERS

          

          

            

09 Aug

Win a Free Company Presentation at #BIF18 with the Buzz of BIO Contest

The provides an excellent opportunity for companies looking to gain exposure and make the connections needed to take their product to the next phase. Winners of the Buzz of BIO contest at the will receive a complimentary and . Presentations are a key programming element, and allow companies to present their pipeline, R&D activities, and future goals to an exclusive audience of private and public equity investors.

Nominations are open today until August 22 at 5 PM ET, or until each category receives ten nominees. Ten biotech’s will be nominated in each of the three categories: Early Stage Entrepreneurs, Late Stage Leaders, and Diagnostics and Beyond. After the nominations period, voting will open and the companies with the most number of votes win.

  • To qualify for the Early Stage Entrepreneur Grand Prize, companies must be actively developing a therapeutic product intended for FDA review that addresses human health issues and have raised less than $25 million USD as of July 1, 2018; have been founded after 2015; and have most recently completed either a Seed or Series A financing round. Companies that have previously presented at the BIO Investor Forum are not eligible for the Early Stage Entrepreneur category but are welcome to apply under the Late Stage Leader category (if the company meets the minimum dollar requirements of the Late Stage Leader category).
  • To qualify for the Late Stage Leader Grand Prize, companies must be actively developing a therapeutic product intended for FDA review that addresses human health issues and have raised more than $25 million USD as of July 1, 2018 and have enrolled at least one patient in a company-sponsored clinical trial posted at https://clinicaltrials.gov.
  • To qualify for the Diagnostics and Beyond category, companies must be primarily focused in medical diagnostics, drug delivery, drug development tools, or digital health technologies.

To nominate your company for Buzz of BIO, .

The BIO Investor Forum is an international biotech investor conference focused on investment opportunities in life sciences, with emphasis on venture-stage growth and emerging public companies as well as those poised to join the growth “watch-list” in 2019. The event features plenary sessions, business roundtables and therapeutic workshops, more than 160 public and venture-stage company presentations, premiere industry-focused networking opportunities, and over 2,700 BIO One-on-One Partnering™ meetings.

Don’t miss this exciting opportunity to be recognized. Good luck!

rates are available through September 9is also available for qualified members of the press.

*Due to the complexities of international laws regarding contests, only U.S. residents who are 21 years of age or older are eligible to enter.

09 Aug

Development and long-term sustainability of new pan-European research infrastructures

[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: H2020-INFRADEV-2018-2020Pillar: Excellent SciencePlanned Opening Date: Deadline: Wed, 20 Mar 2019 17:00:00 (Brussels local time)Modification Date: Thu, 9 Aug 2018Latest information:
Please be informed that the call opening for the topic INFRADEV-02-2019-2020 (CSA) has been postponed to 14/11/2018 and the call deadline to 20/03/2019.

09 Aug

BUILDING A LOW-CARBON, CLIMATE RESILIENT FUTURE: SECURE, CLEAN AND EFFICIENT ENERGY

[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: H2020-LC-SC3-2018-2019-2020Pillar: Societal ChallengesPlanned Opening Date: Deadline: Wed, 11 Dec 2019 17:00:00 (Brussels local time)Modification Date: Wed, 8 Aug 2018Latest information: The submission deadline of 04 September 2018 in theH2020-LC-SC3-EE-2018 call has been extended to13 September 2018 at 17:00 (Brussels local time). This extension applies to the following topics:
– LC-SC3-EE-1-2018-2019-2020(IA)
-LC-SC3-EE-2-2018-2019(CSA)
– LC-SC3-EE-5-2018-2019-2020(CSA)
– LC-SC3-EE-6-2018-2019-2020(IA)
– LC-SC3-EE-8-2018-2019(CSA)
– LC-SC3-EE-9-2018-2019(CSA)
– LC-SC3-EE-10-2018-2019-2020(CSA)
– LC-SC3-EE-11-2018-2019-2020(CSA)
– LC-SC3-EE-13-2018-2019-2020(CSA)
– LC-SC3-EE-14-2018-2019-2020(RIA)
– LC-SC3-EE-15-2018(CSA)
– LC-SC3-EE-16-2018-2019-2020(CSA)
– LC-SC3-EC-1-2018-2019-2020(CSA)
– LC-SC3-EC-2-2018-2019-2020(CSA)

08 Aug

Events – Europe’s Transformation: Where People Matter – Austrian Presidency Event – 14-15 November 2018, Vienna, Austria

[Source: Research & Innovation] The 4th International Growth in Transition Conference: ‘Europe’s Transformation: Where People Matter’, jointly organised by the Federal Ministry of Sustainability and Tourism and the Environment Agency Austria, will link up the transformative processes and power already taking effect within the particular participating institutions. The international conference is supported by 31 stakeholder organisations. The event will focus on exploring economic and societal pathways towards pro-active approaches and a vision of a society that improves the well-being of its citizens. The conference will bring together researchers, professionals, politicians, public officials, entrepreneurs, enthusiasts, practitioners and other civil society groups from Austria and Europe.
Registration is available here: https://growthintransition.eu/conference2018/.

08 Aug

Paratek Eyes FDA Approval of Antibiotic After Advisory Panel Nod

An FDA advisory committee voted to recommend U.S. approval of Paratek Pharmaceuticals’ experimental antibiotic, omadacycline, both for the treatment of certain types of bacterial skin infections and hospital-acquired pneumonia.

The independent advisory panel’s endorsement isn’t binding, but the FDA often follows the guidance of such committees. The FDA’s decision is expected in early October, Boston-based Paratek (NASDAQ: PRTK) said in a press release announcing the positive vote. Pending approval, Paratek plans to start selling the drug next year.

Trading of Paratek shares was halted much of Wednesday, but ticked up 1 percent, to $11 apiece, when trading resumed in the… Read more »

UNDERWRITERS AND PARTNERS

          

          

            

08 Aug

No Seriously - Trust the Experts

Well, it’s official. We’ve finally reach the point where people are getting their advice from celebrities rather than scientists on science and medical issues. It’s fine when a celebrity takes up a cause like Alzheimer’s Disease, works with the Alzheimer’s Association, and goes to the Hill to advocate funding. Michael J. Fox, Christopher Reeve, Elton John – all celebrities using their fame to advocate for research for cures and treatments.

But there’s a big difference between a celebrity working with a leading reputable organization to affect change, and a celebrity just spouting their thoughts on Facebook or Twitter with no input from the leading scientists or doctors on very complex issues

Last week, the Washington Post published a review of a new book by Paul A. Offit, “Bad Advice: Or Why Celebrities, Politicians, and Activists Aren’t Your Best Source of Health Information,” which takes a close look at the harmful implications of the emerging trend. Offit, if you’re unaware, is a leading expert on the safety and necessity of vaccines, so he knows what he’s talking about.

GMO Answers has been driving home the message of listening to actual experts and not celebrities for five years.  Our entire campaign, in fact, is based on the idea that experts who actually grow and develop GMOs will answers any and all questions you have about GMOs. Using the book review of Dr. Offit’s book as an inspiration, we wrote a Medium blog post that highlights some of the pitfalls of listening to unqualified Hollywood celebrities instead of those who actually know the science around hot button issues, like Offit and vaccines.

We write:

Yet, many celebrities, including Kelly Clarkson, Gwyneth Paltrow, and more, irresponsibly use their platforms to make false statements about the safety and nutritional value of GMOs - a practice now being adopted by several food brands. For example, you can buy non-GMO grapefruit juice and non-GMO tomatoes at many grocery stores, despite the fact that a grapefruit doesn’t have a GMO counterpart, and there are no GMO tomatoes on the market. Some take it a step further - like Stonyfield, which ran an ad earlier this year featuring school-aged kids perpetuating GMO myths.

So if you have questions about GMOs, submit a question to GMO Answers or explore the website. Don’t just randomly listen to food and diet advice from a Hollywood celebrity. Get you information from people who know the issue best, the farmers who grow them, the scientists who develop them, and the dietitians who have been trained to look at the scientific literature to know that GMOs are safe to eat, and just as healthy and nutritious as any other food.

08 Aug

Parkland school shooting suspect Nikolas Cruz confession video released

Parkland school shooting suspect Nikolas Cruz confession video released
A Broward County judge has ordered that parts of the confession made to police by Florida school shooting suspect Nikolas Cruz should be released to the public. Cruz admits in the video he had been hearing a voice or demons speaking to him for years –
“Burn, kill, destroy,” he said the “evil” voice told him.

For more info, please go to http://www.globalnews.ca
Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
[Read More …]